A conditional maximized sequential probability ratio test for pharmacovigilance
- PMID: 19941282
- DOI: 10.1002/sim.3780
A conditional maximized sequential probability ratio test for pharmacovigilance
Abstract
The importance of post-marketing surveillance for drug and vaccine safety is well recognized as rare but serious adverse events may not be detected in pre-approval clinical trials. In such surveillance, a sequential test is preferable, in order to detect potential problems as soon as possible. Various sequential probability ratio tests (SPRT) have been applied in near real-time vaccine and drug safety surveillance, including Wald's classical SPRT with a single alternative and the Poisson-based maximized SPRT (MaxSPRT) with a composite alternative. These methods require that the expected number of events under the null hypothesis is known as a function of time t. In practice, the expected counts are usually estimated from historical data. When a large sample size from the historical data is lacking, the SPRTs are biased due to the variance in the estimate of the expected number of events. We present a conditional maximized sequential probability ratio test (CMaxSPRT), which adjusts for the uncertainty in the expected counts. Our test incorporates the randomness and variability from both the historical data and the surveillance population. Evaluations of the statistical power for CMaxSPRT are presented under different scenarios.
Similar articles
-
Continuous sequential boundaries for vaccine safety surveillance.Stat Med. 2014 Aug 30;33(19):3387-97. doi: 10.1002/sim.6161. Epub 2014 Apr 1. Stat Med. 2014. PMID: 24691986
-
Decision support methods for the detection of adverse events in post-marketing data.Drug Discov Today. 2009 Apr;14(7-8):343-57. doi: 10.1016/j.drudis.2008.12.012. Epub 2009 Jan 31. Drug Discov Today. 2009. PMID: 19187799 Review.
-
Early detection of adverse drug events within population-based health networks: application of sequential testing methods.Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1275-84. doi: 10.1002/pds.1509. Pharmacoepidemiol Drug Saf. 2007. PMID: 17955500
-
Real-time vaccine safety surveillance for the early detection of adverse events.Med Care. 2007 Oct;45(10 Supl 2):S89-95. doi: 10.1097/MLR.0b013e3180616c0a. Med Care. 2007. PMID: 17909389
-
[Pharmacovigilance of vaccines].Arch Pediatr. 2006 Feb;13(2):175-80. doi: 10.1016/j.arcped.2005.10.020. Epub 2005 Dec 15. Arch Pediatr. 2006. PMID: 16343870 Review. French.
Cited by
-
Mining adverse events in large frequency tables with ontology, with an application to the vaccine adverse event reporting system.Stat Med. 2023 May 10;42(10):1512-1524. doi: 10.1002/sim.9684. Epub 2023 Feb 15. Stat Med. 2023. PMID: 36791465 Free PMC article.
-
A seasonality-adjusted sequential test for vaccine safety surveillance.Biometrics. 2023 Dec;79(4):3533-3548. doi: 10.1111/biom.13829. Epub 2023 Jan 30. Biometrics. 2023. PMID: 36645553 Free PMC article.
-
Exact sequential test for clinical trials and post-market drug and vaccine safety surveillance with Poisson and binary data.Stat Med. 2021 Sep 30;40(22):4890-4913. doi: 10.1002/sim.9094. Epub 2021 Jun 13. Stat Med. 2021. PMID: 34120357 Free PMC article.
-
Vaccine adverse event enrichment tests.Stat Med. 2021 Aug 30;40(19):4269-4278. doi: 10.1002/sim.9027. Epub 2021 May 9. Stat Med. 2021. PMID: 33969520 Free PMC article.
-
Improvement in the Analysis of Vaccine Adverse Event Reporting System Database.Stat Biopharm Res. 2020;12(3):303-310. doi: 10.1080/19466315.2020.1764862. Epub 2020 Jun 8. Stat Biopharm Res. 2020. PMID: 33880140 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical